Search

everythinglearnresearchcommunity

for

Search:↓

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

The FDA approved using Cialis with Proscar for better treatment options.

Cilostazol may help hair grow and could be a new treatment for hair loss.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

A reliable method was developed to measure Finasteride and Tadalafil together, showing they degrade under certain conditions.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Micelles can change cetirizine's ionization, affecting its effectiveness in treatments.

The method accurately measures cyproterone acetate in plasma, showing no significant difference between two formulations.

Ticagrelor works better than clopidogrel in reducing platelet activity in elderly patients with acute coronary syndrome.

Flutamide and CPA are more effective than finasteride for treating acne in hyperandrogenic women.

Finasteride increases CD8+ T cells in BPH tissues.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

Entadfi, a mix of finasteride and tadalafil, is used for BPH.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

CTP-543 is generally safe for treating alopecia areata.

Doxazosin and finasteride negatively affect sexual function in men with BPH.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

The MPA-ISO cocrystal improved solubility and dissolution rate, while the others did not.

Regulatory challenges make developing combination therapies in urology difficult and costly.